Journal Article10.1586/ERI.11.90
Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens
176
TL;DR: Recent animal and human trials show phages to be safe, well-tolerated agents with a bright future as an alternative to chemical agents.
read more
Abstract: The use of bacteriophages (phages) to treat bacterial infections, known as phage therapy, has a history substantially longer than that of antibiotics, yet these drugs have been the treatment of choice in the West for over 60 years owing to efficacy, low toxicity and ease of production. Bacteria are becoming increasingly resistant to antibiotics while efforts to discover new agents have drastically reduced. Phages have co-evolved with their hosts over billions of years and have acquired mechanisms to counter bacterial defences such as extracellular biofilm production, which severely reduces the effectiveness of conventional antibiotics. Recent animal and human trials show phages to be safe, well-tolerated agents with a bright future as an alternative to chemical agents.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Bacteriocins — a viable alternative to antibiotics?
TL;DR: Although the application of specific bacteriocins might be curtailed by the development of resistance, an understanding of the mechanisms by which such resistance could emerge will enable researchers to develop strategies to minimize this potential problem.
1.6K
Bacterial Biofilms: Development, Dispersal, and Therapeutic Strategies in the Dawn of the Postantibiotic Era
TL;DR: A general review of the steps leading to biofilm formation on surfaces and within eukaryotic cells is provided, highlighting several medically important pathogens, and recent advances on novel strategies aimed at biofilm prevention and/or dissolution are discussed.
Strategies for combating bacterial biofilm infections
TL;DR: An efficient treatment ofBiofilm infections needs a well-established multidisciplinary collaboration, which includes removal of the infected foreign bodies, selection of biofilm-active, sensitive and well-penetrating antibiotics, systemic or topical antibiotic administration in high dosage and combinations, and administration of anti-quorum sensing or biofilm dispersal agents.
Biofilm infections, their resilience to therapy and innovative treatment strategies
Ute Römling,Carlos Balsalobre +1 more
TL;DR: Cyclic di‐nucleotides are also potential immunotherapeutic agents to treat antibiotic‐resistant bacterial infections and might be appropriate targets for antibiofilm therapy in combination with antibiotic treatment strategies.
841
Antibiotic alternatives: the substitution of antibiotics in animal husbandry?
TL;DR: It is hard to conclude that the alternatives might substitute antibiotics in veterinary medicine in the foreseeable future, but prudent use of antibiotics and the establishment of scientific monitoring systems are the best and fastest way to limit the adverse effects of the abused antibiotics and to ensure the safety of animal-derived food and environment.
References
Bacterial biofilms: from the natural environment to infectious diseases.
TL;DR: It is evident that biofilm formation is an ancient and integral component of the prokaryotic life cycle, and is a key factor for survival in diverse environments.
Origins and Evolution of Antibiotic Resistance
Julian Davies,Dorothy Davies +1 more
TL;DR: A review of antibiotic resistance development over the past half-century can be found in this article, with the oft-restated conclusion that it is time to act and to restore the therapeutic applications of antibiotics.
5.4K
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Helen W. Boucher,George H. Talbot,John S. Bradley,John S. Bradley,John E. Edwards,John E. Edwards,David N. Gilbert,Louis B. Rice,Louis B. Rice,Michael Scheld,Brad Spellberg,Brad Spellberg,John G. Bartlett +12 more
TL;DR: An update on potentially effective antibacterial drugs in the late-stage development pipeline is provided, in the hope of encouraging collaboration between industry, academia, the National Institutes of Health, the Food and Drug Administration, and the Centers for Disease Control and Prevention work productively together.
Origins and evolution of antibiotic resistance
Julian Davies
- 01 Mar 1996
TL;DR: This review presents the salient aspects of antibiotic resistance development over the past half-century, with the oft-restated conclusion that it is time to act.
Antibiotic resistance of bacterial biofilms
TL;DR: Biofilms can be prevented by early aggressive antibiotic prophylaxis or therapy and they can be treated by chronic suppressive therapy and a promising strategy may be the use of enzymes that can dissolve the biofilm matrix as well as quorum-sensing inhibitors that increase biofilm susceptibility to antibiotics.
3.1K
Related Papers (5)
Stephen T. Abedon,Sarah J. Kuhl,Bob G. Blasdel,Elizabeth Kutter +3 more
- 01 Mar 2011
Catherine Loc-Carrillo,Stephen T. Abedon +1 more
- 01 Mar 2011